Your Voice Matters! Raise It To Protect NIH Funding.

Categories: News, Other
down syndrome research
URGENT: Down syndrome research funding is under potential threat. We need your help. Today we are joining our national and international colleagues to urge Congress to work with our President to restore and increase federal funding for the National Institutes of Health (NIH). NIH provides lifesaving and life-changing medical care and research for people with …

Read More

Federal Budget Updates Related to Down Syndrome Research

Categories: Blog, Ds / Alzheimer's Connection, News
Our Dr. Harpold stays closely connected to and works in the world of research, not only Down syndrome and Alzheimer’s disease, but also relevant research endeavors at a broad scale. Here’s his take on the Federal 2016 Omnibus Budget Bill. By Dr. Michael Harpold, LuMind RDS Chief Scientific Officer The just enacted Federal 2016 Omnibus Budget …

Read More

Clinton Campaign Announces Investment Plan for Alzheimer’s Disease

Categories: Blog, Ds / Alzheimer's Connection, News
LuMind Research Down Syndrome Foundation applauds the development and announcement by the Clinton presidential campaign of a formal plan for new investment to prevent, treat, and make an Alzheimer’s disease cure possible by 2025, which includes a commitment to reach the $2 billion annual funding level for NIH’s dementia research. You can read more details on Clinton’s announced plan …

Read More

NIH supports new studies to find Alzheimer’s biomarkers in Down syndrome

Categories: Blog, Ds / Alzheimer's Connection, News

The National Institutes of Health announced a groundbreaking initiative to track dementia onset and the progress of Alzheimer’s disease in people with Down syndrome. The studies will be funded by the National Institute on Aging (NIA) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both part of NIH. “We …

Read More

21st Century Cures Act Passes in US House – What It Means for Down Syndrome Research

Categories: Blog

By Dr. Michael Harpold, LuMind RDS Chief Scientific Officer The 21st Century Cures Act, originating and developed out of the US House Energy and Commerce Committee, has been working its way through to a vote in the US House of Representatives. LuMind RDS signed the letter of support organized by National Health Council, in conjunction with our …

Read More